## Core Concept
The question tests the understanding of the renin-angiotensin-aldosterone system (RAAS) and how different drugs affect plasma renin activity. Plasma renin activity is a measure of the activity of renin, an enzyme released by the kidneys that plays a crucial role in regulating blood pressure. Drugs that affect the RAAS pathway can either increase or decrease plasma renin activity.

## Why the Correct Answer is Right
Propranolol, a non-selective beta-blocker, decreases plasma renin activity. This is because beta-1 receptors in the juxtaglomerular cells of the kidneys stimulate the release of renin. By blocking these beta-1 receptors, propranolol reduces the release of renin, thereby decreasing plasma renin activity. This action is part of how beta-blockers help in managing hypertension.

## Why Each Wrong Option is Incorrect
* **Option A:** ACE inhibitors (e.g., lisinopril) actually increase plasma renin activity. They work by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor that also inhibits renin release through negative feedback. Without this negative feedback, renin levels rise.
* **Option B:** Angiotensin II receptor blockers (ARBs) also increase plasma renin activity. They block the action of angiotensin II at its receptor, preventing vasoconstriction and aldosterone-mediated volume expansion. Like ACE inhibitors, they remove the negative feedback inhibition on renin release.
* **Option D:** Diuretics can increase plasma renin activity. They act by reducing blood volume, which decreases blood pressure and increases sympathetic outflow. This leads to increased renin release.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that beta-blockers like propranolol are effective in treating hypertension, especially in patients with high renin levels. They are often used in combination with other antihypertensive agents to achieve better blood pressure control.

## Correct Answer: C. Propranolol